By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Actinium Pharmaceuticals, Inc. 

501 Fifth Avenue

New York City  New York  10017  U.S.A.
Phone: 646-459-4201 Fax: n/a


SEARCH JOBS








Company News
Actinium Pharmaceuticals, Inc. (ATNM.OB) Release: Strategic Additions In Key Areas Will Support Later Stage Clinical Trials For Iomab-B And Actimab-A 1/27/2016 9:19:33 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At The 18th Annual BIO CEO & Investor Conference 1/21/2016 8:50:13 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Ring First Closing Bell Of 2016 At The New York Stock Exchange 12/28/2015 12:20:30 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) And Memorial Sloan-Kettering Cancer Center Sign Agreement In Respect Of Certain Liquidity Matters 12/28/2015 12:03:52 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Release: Small Cap IR -- Two Clinical Stage Products Lead the Way In A Promising Pipeline 6/3/2015 8:50:23 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Announces Pricing Of Public Offering Of Common Stock And Warrants To Purchase Common Stock 2/6/2015 10:52:56 AM
MD Anderson Cancer Center Department Chair Richard E. Champlin, M.D. Joins Actinium Pharmaceuticals, Inc. (ATNM.OB)’s Iomab™-B Scientific Advisory Board 9/10/2014 10:10:54 AM
Actinium Pharmaceuticals, Inc. (ATNM.OB) Files Orphan Drug Application For Use Of Actimab-A In The Treatment Of Newly Diagnosed Acute Myeloid Leukemia In Elderly Patients 9/3/2014 12:24:53 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At Rodman & Renshaw Annual Global Investment Conference On September 10th 8/28/2014 12:36:42 PM
Actinium Pharmaceuticals, Inc. (ATNM.OB) To Present At The Canaccord Genuity 34th Annual Growth Conference On August 13th 8/5/2014 9:49:29 AM
12345678910...
//-->